The National Institute for Health and Care Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on 27 April 2011. NICE is currently updating this guidance. The new guidance will be published shortly. Until then the NHS should continue to follow the recommendations outlined in the current version of the guidance. The Interventional Procedures Advisory Committee (IPAC) will consider this procedure review and NICE will issue an interventional procedures consultation document about its safety and efficacy for 4 weeks’ public consultation. IPAC will then review the consultation document in the light of comments received and produce a final interventional procedures document, which will be considered by NICE before guidance is issued to the NHS in England, Wales, Scotland and Northern Ireland.
 
Status Awaiting development
Technology type Procedure
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process IP
ID number 881
Description Carotid stenting is usually done with the patient under local anaesthesia. It involves passing a guidewire into the carotid artery, commonly with a cerebral protection device at its tip, which is designed to prevent any debris from passing into the cerebral circulation during the procedure. The carotid stenosis is then usually predilated using a balloon catheter. A metal mesh (stent) is inserted, which keeps the artery open to maintain blood flow and prevent restenosis and embolism. Once the stent has been implanted, the protection device is removed via the delivery catheter. Carotid stenting is a less invasive percutaneous alternative to traditional open surgery (endarterectomy). Potential advantages include avoidance of general anaesthesia, avoidance of an incision in the neck with the risk of cranial and cutaneous nerve damage, and a reduction in the rate of general complications of surgery, for example, myocardial infarction.

Provisional Schedule

IPAC 1 13 April 2023
Interventional procedure consultation 24 May 2023 - 22 June 2023
IPAC 2 10 August 2023
Expected publication 25 October 2023

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
06 May 2022 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on how we develop interventional procedures guidance, please see our IP manual